Investigational Psilocybin for PTSD and Ongoing Trials

Investigational Psilocybin for PTSD and Ongoing Trials

Psychedelic therapy shows promise for treating PTSD, with recent studies indicating safety and efficacy.

Legislation, Industry, and the Future of Psilocybin for PTSD

One of the most widely known psychedelic compounds in the world, psilocybin has been investigated in thousands in clinical trials focused mostly on treatments for  depression and anxiety. That changed last month with the FDA’s announcement that it would approve a new proposal to study psilocybin assisted therapy for post-traumatic stress disorder (PTSD). On January 7, 2026 the FDA accepted Compass Pathway’s Investigational New Drug Application f…